Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xianglei Gao"'
Autor:
Xianglei Gao, Yujing Di, Yuan Lv, Yingcai Luan, Yang Xiong, Yuli Xu, Yusheng Li, Linfeng Guo, Xiaoping Li, Li Deng, Yulei Zhuang, Jie Hou
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 4, Pp n/a-n/a (2024)
Abstract This study aimed to evaluate the pharmacokinetics (PKs), safety, and immunogenicity of the biosimilar HEC14028 compared to reference Trulicity® (dulaglutide) in healthy male Chinese subjects. This study was a single‐center, randomized, op
Externí odkaz:
https://doaj.org/article/ed5a962c056a4f96a6e28ac95d130d16
Autor:
Ruirui Zhou, Linfeng Guo, Xianglei Gao, Yijun Wang, Wenjing Xu, Yang Zou, Wenjia Li, Yulei Zhuang, Gangyi Liu, Yanmei Liu
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 10, Pp 2458-2467 (2022)
Abstract This study aimed to evaluate the pharmacokinetics (PKs), safety, and immunogenicity of the biosimilar (RD12014) compared to reference liraglutide (Victoza) in healthy Chinese male subjects, so as to provide the basis for the similarity evalu
Externí odkaz:
https://doaj.org/article/ca5a6593c1e84b88bb977b782ce8dc66
Autor:
Qi Pan, Shushan Lin, Yu Li, Liang Liu, Xiaoping Li, Xianglei Gao, Jiangyu Yan, Baohua Gu, Xiaofeng Chen, Wenjia Li, Xinfa Tang, Chao Chen, Lixin Guo
Publikováno v:
EBioMedicine, Vol 63, Iss , Pp 103202- (2021)
Background: Fibroblast growth factor 21 (FGF21) has become a promising therapeutic target for metabolic diseases such as type 2 diabetes (T2D), obesity and non-alcoholic steatohepatitis. However, the clinical application of natural FGF21 molecule is
Externí odkaz:
https://doaj.org/article/7e596c8625a2436db136e1239e8fa2dd
Autor:
Li Yu, Xianglei Gao, Wenjia Li, Jiangyu Yan, Chen Chao, Chen Xiaofeng, Xinfa Tang, Lin Shushan, Qi Pan, Li Xiaoping, Liu Liang, Lixin Guo, Baohua Gu
Publikováno v:
EBioMedicine
EBioMedicine, Vol 63, Iss, Pp 103202-(2021)
EBioMedicine, Vol 63, Iss, Pp 103202-(2021)
Background: Fibroblast growth factor 21 (FGF21) has become a promising therapeutic target for metabolic diseases such as type 2 diabetes (T2D), obesity and non-alcoholic steatohepatitis (NASH). However, the clinical application of natural FGF21 molec
Autor:
Xianglei Gao1, Wei Chen1, Chaowan Guo2, Chuiwen Qian1, Ge Liu2, Feng Ge1, Yadong Huang1, Kaio Kitazato2, Yifei Wang1, Sheng Xiong1,2 xiongsheng@jnu.edu.cn
Publikováno v:
Applied Microbiology & Biotechnology. Jan2010, Vol. 85 Issue 4, p1051-1060. 10p. 2 Diagrams, 1 Chart, 3 Graphs.
Autor:
Wang Yifei, Kaio Kitazato, Feng Ge, Ge Liu, Yadong Huang, Xianglei Gao, Chuiwen Qian, Guo Chaowan, Sheng Xiong, Wei Chen
Publikováno v:
Applied Microbiology and Biotechnology
Cyanovirin-N (CVN) is a promising antiviral candidate that has an extremely low sequence homology with any other known proteins. The efficient and soluble expression of biologically functional recombinant CVN (rCVN) is still an obstacle due to insuff